“Phenobarbital for Moderate to Severe Alcohol Withdrawal in the Acute Care Setting”
Event Navigation
HealthTrust presents…
“Phenobarbital for Moderate to Severe Alcohol Withdrawal in the Acute Care Setting”
Download a PDF copy of this presentation here. Listen to a recording of this presentation here.
In this presentation, presenters will explore the fluctuation of neurotransmitters in an alcoholic patient, the mechanism of action of phenobarbital in alcohol withdrawal and a dosing strategy for phenobarbital. The session will feature results from a pilot study completed at a community hospital illustrating how implementing a “pharmacy to dose” phenobarbital regimen decreased the amount of patients receiving dexmedetomidine and benzodiazepam use, understanding nursing monitoring parameters and side effects of the medication.
Learning Objectives:
- Describe the mechanism of action of phenobarbital in treating patients with alcohol withdrawal symptoms
- Explain patient management and treatment goals when treating moderate to severe alcohol withdrawal symptoms with phenobarbital
- Describe potential protocols to decrease the amount of dexmedetomidine and benzodiazepines that are used in their institutional settings for treating patients with alcohol withdrawal symptoms
Presenters:
Christopher Devine, PharmD, BCPS, Critical Care Pharmacist – Portsmouth Regional Hospital
Karen Michaud, PharmD, Clinical Manager – Portsmouth Regional Hospital
There is no cost associated with this program.
Target audience: Pharmacy
Continuing Education Credit:
- Pharmacy: Belmont University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The ACPE Universal Activity Number for this activity is 0863-9999-17-050-L04-P. The activity is approved for 1 hour (.1 CEUs) of continuing education credit to pharmacists who attend the webinar and complete the online evaluation.
